Lauric Acid-Coated Magnetic Nanoparticles for Targeted Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current magnetic nano-particle compositions for targeted therapy are laborious to synthesize, expensive, and limited in application, with coatings that fail to meet demands for stability, loading capability, and sterility, making them unsuitable for various therapeutic and imaging applications.
Innovation Solution
A pharmaceutical composition comprising magnetic nano-particles with a lauric acid coating, which allows for efficient loading and adherence of mitoxantrone via electrostatic interaction, providing stability and biocompatibility, and enabling magnetic targeting under external magnetic fields for cancer treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional magnetic nano-particle compositions are used for targeted therapy, then therapeutic agents can be delivered to regional areas, but the synthesis is laborious and expensive with limited application fields
Solution Approach 1:
The patent combines multiple functions into a single nano-particle composition: the magnetic core provides targeting, the lauric acid coating provides stability and biocompatibility, and the electrostatic binding provides drug loading capability. This integration eliminates the need for separate synthesis steps for different functional components, simplifying manufacturing while maintaining targeted delivery reliability
Solution Approach 2:
The lauric acid-coated magnetic nano-particles are designed to be universally applicable for delivering various therapeutic agents through electrostatic interactions. The composition can be used across different application fields (cancer therapy, imaging, regional drug delivery) without requiring individualized modifications, making the synthesis process cost-effective and scalable
2Stability of the object's composition
If conventional coatings are used on magnetic nano-particles, then particles can be stabilized, but they fail to satisfy demands for stability, loading capability and sterility
Solution Approach 1:
The patent changes the coating material parameter from conventional polymers (dextran, starch, PEG) to lauric acid, which provides optimal balance of stability, biocompatibility, and electrostatic binding capability. The specific coating thickness and composition ratio are optimized to ensure both particle stability in circulation and high drug loading capability through electrostatic interactions
Solution Approach 2:
The nano-particles comprise a composite structure with a magnetic core (Fe3O4 or Fe2O3) and a lauric acid coating layer. This composite design combines the magnetic properties of the core with the biocompatible, electrostatically-active properties of the fatty acid coating, achieving simultaneous stability, loading capability, and sterility requirements
3Reliability
If systemic dosage is increased to improve therapeutic efficacy, then treatment effectiveness increases, but side effects increase
Solution Approach 1:
The patent segments the therapeutic dose by delivering the drug locally to the target region through magnetic targeting rather than systemic administration. The magnetic nano-particles concentrate the therapeutic agent at the disease site (e.g., tumor), allowing effective local dosing while minimizing exposure of healthy tissues to the drug, thereby reducing systemic side effects
Solution Approach 2:
The magnetic nano-particles act as intermediaries that carry the therapeutic agent from the circulation to the target tissue. By using an external magnetic field to guide the particles to the disease site, the system enables selective drug delivery, achieving high local concentration with low systemic dosage, thus improving efficacy while minimizing harmful side effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves targeted delivery of therapeutic agents to local disease areas with reduced systemic dosage, minimizing side effects and enhancing therapeutic efficacy while maintaining stability and sterility, suitable for clinical use.
Implementation Method 1
The composition is guided and accumulated to the target tissue by means of an external magnetic field gradient
Implementation Method 2
wherein the magnetic particles further comprise mitoxantrone, which is adhered directly onto the surface of the particle cores and/or into the inside of an aggregate of the particle cores by electrostatic interaction
Data Source
Figure 1
Figure 2a~2b
Figure 3
AI summary
The invention relates to a pharmaceutical composition comprising magnetic nano-particles for magnetic targeting of drugs and imaging agents. The invention further relates to the use of said pharmaceutical composition as a drug carrier, for use as an imaging agent, for use as a medicament and specifically for use in cancer treatment by magnetic drug targeting using an external magnetic field. The present invention also relates to a method for manufacturing said pharmaceutical composition and a method for guiding and accumulating said pharmaceutical composition to a target tissue contained in a subject.